MeCP2 phosphorylation in the brain: From transcription to behavior

Biological Chemistry

Volumn 394, Issue 12, 2013, Pages 1595-1605

  Damen, Daniela ^a   Heumann, Rolf ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

DNA methylation; Intellectual disability; Protein phosphorylation; Rett syndrome; X linked neurologic disorder

Indexed keywords

COCAINE; CYTOSINE; METHYL CPG BINDING PROTEIN 2;

BRAIN MATURATION; DNA BINDING; DNA METHYLATION; DRUG DEPENDENCE; GENE EXPRESSION; HUMAN; LEARNING; MAMMAL; MEMORY; METHYLATION; MOOD DISORDER; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW;

ANIMALS; BRAIN; CYTOSINE; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; LEARNING; MEMORY; METHYL-CPG-BINDING PROTEIN 2; MOOD DISORDERS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBSTANCE-RELATED DISORDERS; TRANSCRIPTION, GENETIC;

EID: 84888084654     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0193     Document Type: Review

References (66)

1. Agarwal, N., Hardt, T., Brero, A., Nowak, D., Rothbauer, U., Becker, A., Leonhardt, H., and Cardoso, M.C. (2007). MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res. 35, 5402-5408. (Pubitemid 47423914)
2. Armstrong, D., Dunn, J.K., Antalffy, B., and Trivedi, R. (1995). Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol. 54, 195-201.
3. Ballas, N., Lioy, D.T., Grunseich, C., and Mandel, G. (2009). Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci. 12, 311-317.
4. Bird, A.P. and Wolffe, A.P. (1999). Methylation-induced repression - belts, braces, and chromatin. Cell 99, 451-454. (Pubitemid 129746827)
5. Bodda, C., Tantra, M., Mollajew, R., Arunachalam, J.P., Can, K., Rosenberger, A., Mironov, S.L., Ehrenreich, H., and Mannan, A.U. (2013). Mild overexpression of Mecp2 in mice causes a higher susceptibility toward seizures. Am. J. Pathol. 183, 195-210.
6. Bracaglia, G., Conca, B., Bergo, A., Rusconi, L., Zhou, Z., Greenberg, M.E., Landsberger, N., Soddu, S., and Kilstrup-Nielsen, C. (2009). Methyl-CpG-binding protein 2 is phosphorylated by homeodomain-interacting protein kinase 2 and contributes to apoptosis. EMBO Rep. 10, 1327-1333.
7. Calfa, G., Percy, A.K., and Pozzo-Miller, L. (2011). Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp. Biol. Med. (Maywood) 236, 3-19.
8. Carouge, D., Host, L., Aunis, D., Zwiller, J., and Anglard, P. (2010). CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol. Dis. 38, 414-424.
9. Cassel, S., Carouge, D., Gensburger, C., Anglard, P., Burgun, C., Dietrich, J.B., Aunis, D., and Zwiller, J. (2006). Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol. Pharmacol. 70, 487.
10. Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T.C., Qin, J., and Zoghbi, H.Y. (2008). MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224-1229. (Pubitemid 351929512)
11. Chao, H.-T. and Zoghbi, H.Y. (2012). MeCP2: only 100% will do. Nat. Neurosci. 15, 176-177.
12. Chen, R.Z., Akbarian, S., Tudor, M., and Jaenisch, R. (2001). Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27, 327-331. (Pubitemid 32201857)
13. Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.C., Jaenisch, R., and Greenberg, M.E. (2003). Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885-889. (Pubitemid 37339632)
14. Cohen, S., Gabel, H.W., Hemberg, M., Hutchinson, A.N., Sadacca, L.A., Ebert, D.H., Harmin, D.A., Greenberg, R.S., Verdine, V.K., Zhou, Z., et al. (2011). Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72-85.
15. Colantuoni, C., Jeon, O.H., Hyder, K., Chenchik, A., Khimani, A.H., Narayanan, V., Hoffman, E.P., Kaufmann, W.E., Naidu, S., and Pevsner, J. (2001). Gene expression profiling in postmortem Rett syndrome brain: differential gene expression and patient classification. Neurobiol. Dis. 8, 847-865. (Pubitemid 33055600)
16. Collins, A.L., Levenson, J.M., Vilaythong, A.P., Richman, R., Armstrong, D.L., Noebels, J.L., David Sweatt, J., and Zoghbi, H.Y. (2004). Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679-2689. (Pubitemid 39485416)
17. Dani, V.S., Chang, Q., Maffei, A., Turrigiano, G.G., Jaenisch, R., and Nelson, S.B. (2005). Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. USA 102, 12560-12565. (Pubitemid 41266398)
18. Deng, J.V., Rodriguiz, R.M., Hutchinson, A.N., Kim, I.-H., Wetsel, W.C., and West, A.E. (2010). MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants. Nat. Neurosci. 13, 1128-1136.
19. Dephoure, N., Zhou, C., Villén, J., Beausoleil, S.A., Bakalarski, C.E., Elledge, S.J., and Gygi, S.P. (2008). A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. USA 105, 10762-10767.
20. Fyffe, S.L., Neul, J.L., Samaco, R.C., Chao, H.-T., Ben-Shachar, S., Moretti, P., McGill, B.E., Goulding, E.H., Sullivan, E., Tecott, L.H., et al. (2008). Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron 59, 947-958.
21. Gonzales, M.L., Adams, S., Dunaway, K.W., and Lasalle, J.M. (2012). Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Mol. Cell. Biol. 32, 2894-2903.
22. Hagberg, B.A. and Skjeldal, O.H. (1994). Rett variants: a suggested model for inclusion criteria. Pediatr. Neurol. 11, 5-11. (Pubitemid 24267725)
23. Ho, K.L., McNae, I.W., Schmiedeberg, L., Klose, R.J., Bird, A.P., and Walkinshaw, M.D. (2008). MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol. Cell 29, 525-531. (Pubitemid 351282541)
24. Hutchinson, A.N., Deng, J.V., Aryal, D.K., Wetsel, W.C., and West, A.E. (2011). Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin. Neuropsychopharmacology 37, 321-337.
25. Hutchinson, A.N., Deng, J.V., Cohen, S., and West, A.E. (2012). Phosphorylation of MeCP2 at Ser421 contributes to chronic antidepressant action. J. Neurosci. 32, 14355-14363.
26. Huttlin, E.L., Jedrychowski, M.P., Elias, J.E., Goswami, T., Rad, R., Beausoleil, S.A., Villén, J., Haas, W., Sowa, M.E., and Gygi, S.P. (2010). A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174-1189.
27. Ide, S., Itoh, M., and Goto, Y. (2005). Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse. Neurosci. Lett. 386, 14-17. (Pubitemid 41019635)
28. Im, H.-I., Hollander, J.A., Bali, P., and Kenny, P.J. (2010). MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat. Neurosci. 13, 1120-1127.
29. Jaenisch, R. and Bird, A. (2003). Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33 Suppl, 245-254. (Pubitemid 36278835)
30. Jan, M.M., Dooley, J.M., and Gordon, K.E. (1999). Male Rett syndrome variant: application of diagnostic criteria. Pediatr. Neurol. 20, 238-240. (Pubitemid 29166471)
31. Kudo, S., Nomura, Y., Segawa, M., Fujita, N., Nakao, M., Dragich, J., Schanen, C., and Tamura, M. (2001). Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev. 23 Suppl 1, S165-S173.
32. Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F., and Bird, A. (1992). Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905-914.
33. Li, H., Zhong, X., Chau, K.F., Williams, E.C., and Chang, Q. (2011). Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nat. Neurosci. 14, 1001-1008.
34. Lioy, D.T., Garg, S.K., Monaghan, C.E., Raber, J., Foust, K.D., Kaspar, B.K., Hirrlinger, P.G., Kirchhoff, F., Bissonnette, J.M., Ballas, N., et al. (2011). A role for glia in the progression of Rett's syndrome. Nature 475, 497-500.
35. Luikenhuis, S., Giacometti, E., Beard, C.F., and Jaenisch, R. (2004). Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl. Acad. Sci. USA 101, 6033-6038. (Pubitemid 38520523)
36. Maezawa, I. and Jin, L.-W. (2010). Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J. Neurosci. 30, 5346-5356.
37. Mao, L.-M., Horton, E., Guo, M.-L., Xue, B., Jin, D.-Z., Fibuch, E.E., and Wang, J.Q. (2011). Cocaine increases phosphorylation of MeCP2 in the rat striatum in vivo: a differential role of NMDA receptors. Neurochem. Int. 59, 610-617.
38. McClung, C.A. and Nestler, E.J. (2008). Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33, 3-17. (Pubitemid 350191310)
39. Meins, M., Lehmann, J., Gerresheim, F., Herchenbach, J., Hagedorn, M., Hameister, K., and Epplen, J.T. (2005). Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J. Med. Genet. 42, e12.
40. Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S., and Heintz, N. (2012). MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417-1430.
41. Na, E.S., Nelson, E.D., Kavalali, E.T., and Monteggia, L.M. (2012). The impact of MeCP2 loss- or gain-of-function on synaptic plasticity. Neuropsychopharmacology 38, 212-219.
42. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N., and Bird, A. (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389. (Pubitemid 28269714)
43. Neul, J.L. (2012). The relationship of Rett syndrome and MECP2 disorders to autism. Dialogues Clin. Neurosci. 14, 253-262.
44. Neul, J.L., Kaufmann, W.E., Glaze, D.G., Christodoulou, J., Clarke, A.J., Bahi-Buisson, N., Leonard, H., Bailey, M.E.S., Schanen, N.C., Zappella, M., et al. (2010). Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 68, 944-950.
45. Nguyen, M.V.C., Du, F., Felice, C.A., Shan, X., Nigam, A., Mandel, G., Robinson, J.K., and Ballas, N. (2012). MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J. Neurosci. 32, 10021-10034.
46. Peters, S.U., Hundley, R.J., Wilson, A.K., Warren, Z., Vehorn, A., Carvalho, C.M.B., Lupski, J.R., and Ramocki, M.B. (2013). The behavioral phenotype in MECP2 duplication syndrome: a comparison with idiopathic autism. Autism Res. 6, 42-50.
47. Ramocki, M.B., Tavyev, Y.J., and Peters, S.U. (2010). The MECP2 duplication syndrome. Am. J. Med. Genet. A 152A, 1079-1088.
48. Rett, A. (1966). On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien. Med. Wochenschr. 116, 723-726.
49. Rigbolt, K.T.G., Prokhorova, T.A., Akimov, V., Henningsen, J., Johansen, P.T., Kratchmarova, I., Kassem, M., Mann, M., Olsen, J.V., and Blagoev, B. (2011). System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci. Signal. 4, rs3.
50. Rinschen, M.M., Yu, M.-J., Wang, G., Boja, E.S., Hoffert, J.D., Pisitkun, T., and Knepper, M.A. (2010). Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells. Proc. Natl. Acad. Sci. USA 107, 3882-3887.
51. Samaco, R.C., Mandel-Brehm, C., Chao, H.-T., Ward, C.S., Fyffe-Maricich, S.L., Ren, J., Hyland, K., Thaller, C., Maricich, S.M., Humphreys, P., et al. (2009). Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc. Natl. Acad. Sci. USA 106, 21966-21971.
52. Samaco, R.C., Mandel-Brehm, C., McGraw, C.M., Shaw, C.A., McGill, B.E., and Zoghbi, H.Y. (2012). Crh and Oprm1 mediate anxietyrelated behavior and social approach in a mouse model of MECP2 duplication syndrome. Nat. Genet. 44, 206-211.
53. Sansom, D., Krishnan, V.H., Corbett, J., and Kerr, A. (1993). Emotional and behavioural aspects of Rett syndrome. Dev. Med. Child Neurol. 35, 340-345. (Pubitemid 23101039)
54. Shahbazian, M.D., Antalffy, B., Armstrong, D.L., and Zoghbi, H.Y. (2002). Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11, 115-124. (Pubitemid 34157003)
55. Shiromizu, T., Adachi, J., Watanabe, S., Murakami, T., Kuga, T., Muraoka, S., and Tomonaga, T. (2013). Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-Centric Human Proteome Project. J. Proteome Res. 12, 2414-2421.
56. Skene, P.J., Illingworth, R.S., Webb, S., Kerr, A.R.W., James, K.D., Turner, D.J., Andrews, R., and Bird, A.P. (2010). Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37, 457-468.
57. Tao, J., Hu, K., Chang, Q., Wu, H., Sherman, N.E., Martinowich, K., Klose, R.J., Schanen, C., Jaenisch, R., Wang, W., et al. (2009). Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc. Natl. Acad. Sci. USA 106, 4882-4887.
58. Tudor, M., Akbarian, S., Chen, R.Z., and Jaenisch, R. (2002). Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl. Acad. Sci. USA 99, 15536-15541. (Pubitemid 35403969)
59. Tweedie-Cullen, R.Y., Reck, J.M., and Mansuy, I.M. (2009). Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J. Proteome Res. 8, 4966-4982.
60. Van Esch, H., Bauters, M., Ignatius, J., Jansen, M., Raynaud, M., Hollanders, K., Lugtenberg, D., Bienvenu, T., Jensen, L.R., Gecz, J., et al. (2005). Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77, 442-453. (Pubitemid 41192650)
61. Yang, F., Stenoien, D.L., Strittmatter, E.F., Wang, J., Ding, L., Lipton, M.S., Monroe, M.E., Nicora, C.D., Gristenko, M.A., Tang, K., et al. (2006). Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation. J. Proteome Res. 5, 1252-1260. (Pubitemid 43727805)
62. Young, J.I., Hong, E.P., Castle, J.C., Crespo-Barreto, J., Bowman, A.B., Rose, M.F., Kang, D., Richman, R., Johnson, J.M., Berget, S., et al. (2005). Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl. Acad. Sci. USA 102, 17551-17558. (Pubitemid 41803535)
63. Yu, Y., Yoon, S.-O., Poulogiannis, G., Yang, Q., Ma, X.M., Villén, J., Kubica, N., Hoffman, G.R., Cantley, L.C., Gygi, S.P., et al. (2011). Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-1326.
64. Zeev, B. Ben, Yaron, Y., Schanen, N.C., Wolf, H., Brandt, N., Ginot, N., Shomrat, R., and Orr-Urtreger, A. (2002). Rett syndrome: clinical manifestations in males with MECP2 mutations. J. Child Neurol. 17, 20-24. (Pubitemid 34406881)
65. Zhou, Z., Hong, E.J., Cohen, S., Zhao, W.-N., Ho, H.-Y.H., Schmidt, L., Chen, W.G., Lin, Y., Savner, E., Griffith, E.C., et al. (2006). Brain-specific phosphorylation of MeCP2 regulates activitydependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255-269. (Pubitemid 44548348)
66. Zocchi, L. and Sassone-Corsi, P. (2012). SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression. Epigenetics 7, 695-700.